Frost & Sullivan Recognizes MicroProtein Technologies for its Path-Breaking Production Technology for Recombinant Proteins in Bacteria

Frost & Sullivan Recognizes MicroProtein Technologies for its Path-Breaking Production Technology for Recombinant Proteins in Bacteria PR Newswire MOUNTAIN VIEW, California, Aug. 3, 2012 - MPTxpress technology provides hitherto unseen high-yield percentages as well as environmentally friendly features MOUNTAIN VIEW, California Aug. 3, 2012 /PRNewswire/ -- Based on its recent analysis of the recombinant expression systems market, Frost & Sullivan recognizes MicroProtein Technologies with the 2012 North American Frost & Sullivan Award for Technology Innovation for the development of its proprietary MPTxpress technology that provides a cost-effective production method for pharmaceutically and diagnostically relevant recombinant proteins, along with the highest percentage of yield in the industry. This technology is particularly promising as a production method for biosimilars, biobetters, and biotherapeutics. While employing fermenters for the production of recombinant proteins in bacteria has been a widely accepted practice for two decades, it has limitations in terms of required environmental conditions, storage space, and percentage yield. "The bacterial expression system remains the most preferred choice for recombinant protein expression in the industry due to its versatility and capability to produce homologous, as well as heterologous proteins," explained Frost & Sullivan Research Analyst Ipshita Chakraborty.